Transcription is a peer-reviewed, bi-monthly journal that publishes high-quality articles providing novel insights, provocative questions, and new hypotheses into the expanding field of gene transcription. The journal covers all aspects of transcription: from biochemical and molecular approaches, to cellular, structural, and evolutionary views. In addition to papers that use conventional strategies to study both prokaryotic and eukaryotic transcription, Transcription welcomes manuscripts using state-of-the-art methodologies such as genome-wide analyses, single molecule and biophysical studies, protein structure, imaging, and systems biology.
Transcription is the only journal devoted exclusively to the field of transcription, the process that makes RNA from DNA. It is a forum for the community working on transcription both at the basic and applied levels. Four aspects make Transcription different from other journals in the field:
1. Unique niche covered. There are no other journals devoted to transcription.
2. Multidisciplinary approach. Including: molecular biology, biochemistry, structural
biology, bioinformatics, evolution, next generation sequencing, and imaging.
3. Outstanding Editorial Board. The names are all absolute references in the field of
transcription and world-class molecular biologists including two Nobel laureates
(Thomas Steitz and Roger Kornberg). The Editorial Board has 11 members of the US
National Academy of Sciences that includes the two mentioned Nobel laureates
and Robert Roeder, Robert Singer, Carol Prives, Lucia Rothman-Denes, Frederick Alt,
Jim Manley, Mike Rosbash, Danny Reinberg, and Alberto Kornblihtt (EiC).
4. Fast turnover from submission to acceptance. From reception to first decision is
about 20.16 days. Less than 35 days from reception to final decision.
Transcription offers a rapid and efficient peer review process, as well as a flexible open access (OA) policy. Authors can purchase immediate open access for a reasonable fee. Twelve months after publication, all published papers become free access.
Transcription is indexed in PubMed/MEDLINE.
Landes Bioscience is now part of the Taylor & Francis Group.
- Editor-in-Chief: Alberto R. Kornblihtt, CONICET and Universidad de Buenos Aires, Buenos Aires, Argentina, AR
- Co-Editor-in-Chief: Joaquín M. Espinosa, Linda Crnic Institute for Down Syndrome, University of Colorado
- Acquisitions Editor: Adam Weiss, Prague, CZ